Cullinan Oncology, Inc.

Historical 13F Holders

Symbol
CGEM
CUSIP
230031106
All holders as of
Q3 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for 230031106 since 12/18/2024, largest first.

Filer % of Class Filed
Biotechnology Value Fund L P 13G/A
10.0% 8/14/2026
Event 6/30/2026
Lynx1 Capital Management LP 13G/A
9.8% 11/14/2025
Event 9/30/2025
Price T Rowe Associates Inc /MD/ 13G 6.2% 8/14/2026
Event 6/30/2026
Kynam Capital Management, LP 13G
5.3% 3/4/2026
Event 12/31/2025
Under 5%, checked the "5 percent or less" box, or amended by a later filing (5)
James E. Flynn 13G/A
4.95% 11/13/2025
Event 9/30/2025
State Street Corp 13G 4.0% 11/10/2026
Event 9/30/2026
Franklin Resources, Inc. 13G/A
3.8% 10/31/2024
Event 9/30/2024
Citadel Advisors LLC 13G/A
3.4% 11/14/2025
Event 9/30/2025
Vanguard Group Inc 13G/A 0% 3/26/2026
Event 3/13/2026

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2026 Q3 183 70.1 M $1.08B
2026 Q2 184 71.6 M $1.30B
2026 Q1 174 65.6 M $931M
2025 Q4 154 63.2 M $654M
2025 Q3 145 61.1 M $362M
2025 Q2 145 62.6 M $471M
2025 Q1 150 64.7 M $490M
2024 Q4 148 65.6 M $798M
2024 Q3 138 65.0 M $1.09B
2024 Q2 136 62.9 M $1.10B
2024 Q1 114 39.4 M $671M
2023 Q4 114 36.9 M $376M
2023 Q3 107 38.0 M $344M
2023 Q2 107 36.9 M $397M
2023 Q1 104 32.3 M $330M
2022 Q4 98 37.7 M $398M
2022 Q3 101 37.0 M $475M
2022 Q2 90 37.6 M $482M
2022 Q1 83 36.9 M $386M
2021 Q4 77 36.4 M $560M
2021 Q3 67 33.9 M $762M
2021 Q2 72 32.3 M $829M
2021 Q1 71 31.3 M $1.30B